SLXP : Analysis & Opinions

  1. Salix Gains on Destocking Initiatives, Gives 2-Year Outlook - ...

    December 17, 2014
    Salix (SLXP) expects to resolve its inventory situation a year ahead of schedule and now expects a FDA response on Xifaxan ...
  2. Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook

    November 18, 2014
    Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook
  3. 5 Drug Companies Profiting From Generics

    August 4, 2014
    Leading generic drug maker Teva Pharmaceutical (NYSE: TEVA) posted better-than-expected earnings last week and raised its ...
  4. Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook

    March 25, 2014
    Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook
  5. Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook

    December 3, 2013
    Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook
  6. Dr. Reddy's Launches Generic Lamictal XR - Analyst Blog

    July 1, 2013
    Dr. Reddy's announced the launch of its therapeutic equivalent generic version of Glaxo's Lamictal XR (lamotrigine) extended-release ...
  7. FDA Accepts Pfizer sNDA - Analyst Blog

    June 26, 2013
    The FDA's decision regarding the Xeljanz label expansion should be out by Feb 2014.
  8. US Launch of Forest's Namenda XR - Analyst Blog

    June 17, 2013
    Namenda XR is a once-daily extended-release version of the company's immediate release formulation of Namenda.
  9. ARIAD Closes Offering of Shares - Analyst Blog

    January 30, 2013
    ARIAD Pharmaceuticals, Inc. (ARIA) recently announced the closure of its previously announced public offering. ARIAD Pharma ...
  10. Regeneron Pharmaceuticals Among Healthcare's Biggest Movers on ...

    November 30, 2012
    This morning's trading has marked a bad day for the market so far. The Nasdaq has decreased 0.4%; the S&P 500 has slipped ...
  11. Endo Health Solutions Needs Some Solutions Of Its Own

    November 7, 2012
    Can Endo reestablish itself as a quality healthcare name?
  12. Another Delay for Salix Candidate - Analyst Blog

    September 10, 2012
    The US Food and Drug Administration (FDA) recently informed Salix Pharmaceuticals, Ltd. (SLXP) that it is still reviewing ...
  13. 15 Biotech Companies Waiting For FDA Approval

    March 21, 2012
    Despite all of these uncertainties, investors still heavily focus on whether a company's new drug will be approved by the ...
  14. The Salix Story Keeps Improving

    January 18, 2012
    Salix is a great candidate for growth investors.
Trading Center